| JYSB0500021 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Supplementary Application | 2005-05-12 | | F Hoffmann-La Roche Ltd(Switzerland);Roche Pharma (Schweiz) Ltd | Certificate Issued | 2005-09-23 | view |
| CYSB2400136 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.3) | Supplementary Application | 2024-05-25 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| CYSB2101216 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Supplementary Application | 2021-10-09 | | Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
| CYSB2500082 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(原2) | Supplementary Application | 2025-04-16 | | Shanghai Fuhong Ruilin Biotechnology Co Ltd;Shanghai Henlius Biologics Co Ltd | | | view |
| JYSB2300117 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Supplementary Application | 2023-07-12 | | Genentech Inc;Roche Pharma (Schweiz) AG | | | view |
| CXSS2101019 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.3) | New Drug Application | 2021-08-05 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| CYSB2400292 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.3) | Supplementary Application | 2024-11-09 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| JYSZ2200058 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | License Renew | 2022-11-01 | | Shanghai Roche Pharmaceutical Co Ltd;Genentech Inc;Roche Pharma (Schweiz) AG | | | view |
| CXSS2200005 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.3) | New Drug Application | 2022-01-14 | | Hisun Biopharmaceutical Co Ltd | | | view |
| CYSB2500083 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(原2) | Supplementary Application | 2025-04-16 | | Shanghai Fuhong Ruilin Biotechnology Co Ltd;Shanghai Henlius Biologics Co Ltd | | | view |
| JYSB2300118 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Supplementary Application | 2023-07-12 | | Genentech Inc;Roche Pharma (Schweiz) AG | | | view |
| JYSB2101009 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.1) | Supplementary Application | 2021-04-12 | | Genentech Inc;Roche Pharma (Schweiz) Ltd | | | view |
| CYSB2400281 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.3) | Supplementary Application | 2024-10-25 | | QILU Pharmaceutical Co Ltd | | | view |
| CYSB2101224 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(原2) | Supplementary Application | 2021-10-14 | | Shanghai Henlius Biologics Co Ltd;Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
| JXSL0500008 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(1) | Import Drug Application | 2005-04-01 | | Roche Pharma (Schweiz) Ltd | Certificate Issued | 2005-11-16 | view |
| JYSZ2200057 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | License Renew | 2022-11-01 | | Shanghai Roche Pharmaceutical Co Ltd;Genentech Inc;Roche Pharma (Schweiz) AG | | | view |
| CYSB2500040 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.3) | Supplementary Application | 2025-02-09 | | Hisun Biopharmaceutical Co Ltd | | | view |
| CXSS2300027 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.3) | New Drug Application | 2023-04-27 | | QILU Pharmaceutical Co Ltd | | | view |
| JXSL1300042 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Import Drug Application | 2013-07-08 | | Pfizer Inc | Certificate Issued | 2015-10-15 | view |
| CYSB2101225 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(原2) | Supplementary Application | 2021-10-14 | | Shanghai Henlius Biologics Co Ltd;Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
